论文部分内容阅读
目的:观察普米克令舒及博利康尼雾化吸入治疗喘憋性肺炎的临床疗效。方法:将102例喘憋性肺炎患儿随机分为两组,观察组在综合治疗的基础上给予普米克令舒及博利康尼雾化溶液氧气雾化吸入,对照组在常规治疗方法上加用静滴地塞米松,0.025%爱全乐溶液雾化吸入治疗,比较两组在咳嗽、气喘缓解、哮鸣音消失及住院时间方面的差异。结果:观察组加用普米克令舒及博利康尼雾化溶液吸入后在缓解喘憋症状及哮鸣音消失等方面优于对照组(P<0.05)。结论:普米克令舒及博利康尼氧气面罩雾化吸入治疗喘憋性肺炎有协同作用,可缩短病程,提高治愈率,可做为佐治喘憋性肺炎的主要药物之一。
Objective: To observe the clinical efficacy of pulmicort respules and boliconi inhalation in the treatment of asthmatic pneumonia. Methods: A total of 102 children with asthmatic pneumonia were randomly divided into two groups. The observation group was treated with oxygen inhalation of pulmicort and vasopressin, and the control group was treated with conventional therapy With intravenous dexamethasone, 0.025% Aloe-Lok solution atomized inhalation treatment, the two groups in the cough, asthma relief, wheeze disappearance and hospital stay differences. Results: The observation group was better than the control group (P <0.05) in relieving symptoms of wheezing and disappearance of wheeze after inhaling inhalation of pulmicort and propolis. Conclusion: The combination of pulmicort respules and propolis inhalation aerosol inhalation in the treatment of asthmatic pneumonia has a synergistic effect, which can shorten the course of disease and improve the cure rate. It can be used as one of the main drugs for asthma pneumonia.